Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

Literature DB >> 1703355

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

R Venkataramanan¹, A Jain, V W Warty, K Abu-Elmagd, H Furakawa, O Imventarza, J Fung, S Todo, T E Starzl.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1991 PMID： 1703355 PMCID： PMC3032435

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

8 in total

1. Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors: R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

2. Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

Authors: A B Jain; R Venkataramanan; E Cadoff; J J Fung; S Todo; A Krajack; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors: A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

4. The oral dosage form of FK-506.

Authors: T Honbo; M Kobayashi; K Hane; T Hata; Y Ueda
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

5. A highly sensitive method to assay FK-506 levels in plasma.

Authors: K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

6. Effect of bile on cyclosporin absorption in liver transplant patients.

Authors: M U Mehta; R Venkataramanan; G J Burckart; R J Ptachcinski; B Delamos; S Stachak; D H Van Thiel; S Iwatsuki; T E Starzl
Journal: Br J Clin Pharmacol Date: 1988-05 Impact factor: 4.335

7. Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.

Authors: G Maurer; H R Loosli; E Schreier; B Keller
Journal: Drug Metab Dispos Date: 1984 Jan-Feb Impact factor: 3.922

Review 8. Clinical pharmacokinetics of cyclosporin.

Authors: R J Ptachcinski; R Venkataramanan; G J Burckart
Journal: Clin Pharmacokinet Date: 1986 Mar-Apr Impact factor: 6.447

8 in total

23 in total

1. Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

Authors: A Jain; R Venkataramanan; S Todo; K Abu-Elmagd; J Fung; V Warty; A Tzakis; J Reyes; M Alessiani; T E Starzl
Journal: Transplant Proc Date: 1992-06 Impact factor: 1.066

Review 2. FK 506 and autoimmune disease: perspective and prospects.

Authors: A W Thomson; T E Starzl
Journal: Autoimmunity Date: 1992 Impact factor: 2.815

3. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.

Authors: J J Fung; M Eliasziw; S Todo; A Jain; A J Demetris; J P McMichael; T E Starzl; P Meier; A Donner
Journal: J Am Coll Surg Date: 1996-08 Impact factor: 6.113

4. Pharmacokinetics of FK 506 in transplant patients.

Authors: R Venkataramanan; A Jain; V S Warty; K Abu-Elmagd; M Alessiani; J Lever; A Krajak; J Flowers; S Mehta; S Zuckerman
Journal: Transplant Proc Date: 1991-12 Impact factor: 1.066

5. Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.

Authors: A B Jain; J J Fung; A G Tzakis; R Venkataramanan; K Abu-Elmagd; M Alessiani; J Reyes; W Irish; V Warty; S Mehta
Journal: Transplant Proc Date: 1991-12 Impact factor: 1.066